Lithium Controlled-Release and Extended-Release Tablets and Sulcrate Suspension Plus
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Sulcrate Suspension Plus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: sucralfate
Brand name: Carafate
Synonyms: Sucralfate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Sulf 10
- Lithium Controlled-Release and Extended-Release Tablets-Sulfacetamide
- Lithium Controlled-Release and Extended-Release Tablets-Sulfacetamide and Prednisolone
- Lithium Controlled-Release and Extended-Release Tablets-Sulfacetamide and Prednisolone Eye Drops
- Lithium Controlled-Release and Extended-Release Tablets-Sulfacetamide and Prednisolone Eye Ointment
- Lithium Controlled-Release and Extended-Release Tablets-Sulfacetamide and prednisolone Ophthalmic
- Sulcrate Suspension Plus-Lithium ER
- Sulcrate Suspension Plus-Lithium Oral Solution
- Sulcrate Suspension Plus-Lithium Salts
- Sulcrate Suspension Plus-Lithium Syrup and Oral Solution
- Sulcrate Suspension Plus-Lithobid
- Sulcrate Suspension Plus-Lithostat